EXEL · Healthcare · $14.7B
After-hours $57.940.00%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
10/'26
7/'26 vs prev quarter
Among 327 Biotechnology peers
Quarterly Revenue Growth
“이번 분기 매출 6억 2,900만 달러로 전 분기 대비 계속 증가세를 이어갔어요.”
In the company's words · 2026 2분기 earnings call